Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Arsenicum iodatum is a homeopathic remedy derived from arsenic triiodide, prepared through the homeopathic process of potentization (serial dilution and succussion). It is classified as a mineral-derived homeopathic small molecule with no defined biological target, consistent with traditional homeopathic practice. In clinical research, it has been evaluated as one of four active ingredients in a homeopathic combination product (alongside Agraphis nutans, Thuya occidentalis, and Kalium muriaticum) used as an adjuvant to standard aerosol therapy (ambroxol and budesonide) for the treatment of otitis media with effusion (secretory otitis) in children. Traditionally, Arsenicum iodatum is used in homeopathy for conditions characterized by irritating, corrosive discharges, such as allergic rhinitis, chronic bronchitis, and certain skin conditions like eczema or psoriasis. Its therapeutic claims are based on traditional homeopathic principles and have not been evaluated by regulatory agencies such as the FDA for safety or efficacy in conventional medical terms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on arsenicum iodatum.